SOCS3 as a potential driver of lung metastasis in colon cancer patients

Xuejie Li1, Zuyi Yang2, Bi Chen3,4

  • 1Department of Pathology, The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, China.

Abstract

Insights

Suppressor of cytokine signaling 3 (SOCS3) is linked to poorer colon cancer prognosis and increased immune cell infiltration. High SOCS3 and CD163 expression in lung metastasis suggests a role in tumor progression and potential immunotherapy targets.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The JAK-STAT signaling pathway is crucial in cellular communication and is negatively regulated by suppressor of cytokine signaling 3 (SOCS3).
  • Understanding SOCS3's role in cancer, particularly its interplay with immune cells, is vital for developing effective treatments.

Purpose of the Study:

  • To investigate the expression patterns of SOCS3 in primary colon tumors and their lung metastases.
  • To explore the relationship between SOCS3 status and macrophage markers (CD68, CD163) in colon cancer patients.
  • To elucidate the molecular mechanisms of SOCS3 in lung metastasis using TCGA data.

Main Methods:

  • Utilized immunohistochemistry (IHC) to assess SOCS3, CD68, and CD163 expression in 32 colon cancer patient samples with lung metastasis.
  • Analyzed the correlation between SOCS3 expression and macrophage markers.
  • Employed TCGA database to investigate the molecular mechanisms of SOCS3 in lung metastasis.

Main Results:

  • Higher SOCS3 expression correlated with poorer prognosis and increased immune cell infiltration across various cancer types, notably colon cancer.
  • Lung metastases exhibited higher CD163 and SOCS3 expression compared to primary colon tumors.
  • Elevated SOCS3 expression in lung metastasis was associated with increased CD163 expression, suggesting a link with M2 macrophages.
  • Differentially expressed genes in lung metastasis were significantly enriched in immune response pathways.

Conclusions:

  • SOCS3 demonstrates potential as a prognostic biomarker in various cancers.
  • SOCS3 may serve as a therapeutic target for immunotherapeutic interventions, particularly in colon cancer.
  • Further research into SOCS3's role in tumor progression and immunotherapy is warranted for colon cancer treatment strategies.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K